Questcor Pharma Shares Rise On Strong Q4 Results - NASDAQ PDF Print
NASDAQ
The company expects to complete the expansion of its nephrology sales force to 58 from 28 representatives in the second quarter, ahead of schedule. Questcor said it is currently planning to explore the potential initiation of a commercial effort in

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.